Xylem Analyst Price Targets - Benzinga

Xylem Inc

XYLNYSE

Trade with Public

Trade with Public

$92.40

1.641.81%

Últ. Act.: Oct 30, 4:53 PM

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Dividendos Comparar Opciones Informe de acciones

© 2026 Benzinga | All Rights Reserved

Xylem Analyst Price Targets - Benzinga

Xylem Analyst Price Targets

Wall Street analyst price targets and consensus rating for Xylem (XYL).

Price Target Range — 13 Quarters

Analyst Consensus — 16 Analysts

12Buy

3Hold

1Sell

Consensus RatingBuy# Analysts16Avg. Consensus PT$133Upside to Avg. PT+43.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 29, 2026	UBS	Joshua Spector	PT Cut	Neutral	$112→$99
Oct 29, 2026	Barclays	William Grippin	Downgrade	Overweight→Equal-Weight	$139→$104
Oct 28, 2026	Citigroup	Andrew Kaplowitz	PT Cut	Buy	$148→$130
Oct 28, 2026	BNP Paribas	Andrew Buscaglia	PT Cut	Outperform	$145→$135
Oct 28, 2026	Goldman Sachs	Brian Lee	PT Cut	Buy	$160→$138
Oct 28, 2026	Stifel	Nathan Jones	PT Cut	Buy	$141→$114
Oct 28, 2026	RBC Capital	Jeffrey Reive	PT Cut	Outperform	$135→$125
Oct 28, 2026	Oppenheimer	Bryan Blair	PT Cut	Outperform	$150→$135
Oct 28, 2026	JP Morgan	Michael Fairbanks	Downgrade	Neutral→Underweight	$118→$90
Oct 19, 2026	JP Morgan	Mark Strouse	PT Cut	Neutral	$137→$118
Oct 15, 2026	Mizuho	Brett Linzey	PT Cut	Neutral	$130→$110
Oct 14, 2026	Oppenheimer	Bryan Blair	PT Cut	Outperform	$158→$150
Oct 14, 2026	RBC Capital	Jeffrey Reive	PT Cut	Outperform	$164→$135
Oct 13, 2026	Barclays	William Grippin	PT Cut	Overweight	$159→$139
Oct 12, 2026	Citigroup	Andrew Kaplowitz	PT Cut	Buy	$172→$148
Oct 5, 2026	UBS	Joshua Spector	PT Cut	Neutral	$138→$112
Sep 15, 2026	Wolfe Research	Nigel Coe	Assumes	Peer Perform	—
Aug 24, 2026	Jefferies	Stephen Volkmann	PT Raise	Buy	$145→$150
Aug 13, 2026	UBS	Joshua Spector	PT Raise	Neutral	$135→$138
Jul 30, 2026	UBS	Joshua Spector	PT Raise	Neutral	$129→$135

Analyst Ratings News

PRO
UBS Maintains Neutral on Xylem, Lowers Price Target to $99

UBS analyst Joshua Spector maintains Xylem (NYSE:XYL) with a Neutral and lowers the price target from $112 to $99.

Benzinga Newsdesk

This Lennox International Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Analysts downgraded Renasant, Lennox, Peapack-Gladstone, Alkami and Xylem; price targets for RNST and XYL were cut.

Avi Kapoor

PRO
Barclays Downgrades Xylem to Equal-Weight, Lowers Price Target to $104

Barclays analyst William Grippin downgrades Xylem (NYSE:XYL) from Overweight to Equal-Weight and lowers the price target from $139 to $104.

Benzinga Newsdesk

PRO
Citigroup Maintains Buy on Xylem, Lowers Price Target to $130

Citigroup analyst Andrew Kaplowitz maintains Xylem (NYSE:XYL) with a Buy and lowers the price target from $148 to $130.

Benzinga Newsdesk

PRO
BNP Paribas Maintains Outperform on Xylem, Lowers Price Target to $135

BNP Paribas analyst Andrew Buscaglia maintains Xylem (NYSE:XYL) with a Outperform and lowers the price target from $145 to $135.

Benzinga Newsdesk

PRO
Goldman Sachs Maintains Buy on Xylem, Lowers Price Target to $138

Goldman Sachs analyst Brian Lee maintains Xylem (NYSE:XYL) with a Buy and lowers the price target from $160 to $138.

Benzinga Newsdesk